Pre-treatment patient-specific stopping power by combining list-mode proton radiography and x-ray CT
Pre-treatment patient-specific stopping power by combining list-mode proton radiography and x-ray CT
复制标题
DOI:
10.1088/1361-6560/aa7c42
复制
发表时间:
2017-09-07
影响因子:
3.5
通讯作者:
Seco, Joao
中科院分区:
文献类型:
--
作者:
Collins-Fekete, Charles-Antoine;Brousmiche, Sebastien;Seco, Joao
The relative stopping power (RSP) uncertainty is the largest contributor to the range uncertainty in proton therapy. The purpose of this work was to develop a systematic method that yields accurate and patient-specific RSPs by combining (1) pre-treatment x-ray CT and (2) daily proton radiography of the patient. The method was formulated as a penalized least squares optimization problem (argmin(parallel to Ax - b parallel to(2)(2))). The parameter A represents the cumulative path-length crossed by the proton in each material, separated by thresholding on the HU. The material RSPs (water equivalent thickness/physical thickness) are denoted by x. The parameter b is the list-mode proton radiography produced using Geant4 simulations. The problem was solved using a non-negative linear-solver with x >= 0. A was computed by superposing proton trajectories calculated with a cubic or linear spline approach to the CT. The material's RSP assigned in Geant4 were used for reference while the clinical HU-RSP calibration curve was used for comparison. The Gammex RMI-467 phantom was first investigated. The standard deviation between the estimated material RSP and the calculated RSP is 0.45%. The robustness of the techniques was then assessed as a function of the number of projections and initial proton energy. Optimization with two initial projections yields precise RSP (